SCHEMBL31015992

SCHEMBL31015992

COC(=O)c1sc2cc(F)ccc2c1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCKDK O14874 1/20 0.49
IKBKB O14920 1/20 0.45
RAB9A P51151 3/20 0.44
LMNA P02545 2/20 0.43
MAPK1 P28482 2/20 0.43
HPGD P15428 4/20 0.43
KDM4E B2RXH2 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
GAA P10253 2/20 0.43
KMT2A Q03164 2/20 0.43
TNF P01375 1/20 0.43
NR2F2 P24468 1/20 0.43
HTT P42858 1/20 0.43
MCL1 Q07820 1/20 0.43
KLF5 Q13887 1/20 0.43
NOD1 Q9Y239 1/20 0.43
ALDH1A1 P00352 4/20 0.42
ALOX15 P16050 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25208220 1.00 BCKDK (0.49) BCKDKIKBKBRAB9ALMNAMAPK1
SCHEMBL4654000 0.84 BCKDK (0.50) BCKDKIKBKBRAB9ALMNAMAPK1
SCHEMBL31015908 0.82 BCKDK (0.49) BCKDKIKBKBRAB9ALMNAMAPK1
SCHEMBL25211925 0.82 BCKDK (0.49) BCKDKIKBKBRAB9ALMNAMAPK1
SCHEMBL2955131 0.82 ALDH1A1 (0.64) BCKDKIKBKBMAPK1HPGDKDM4E
SCHEMBL25257143 0.82 RXFP1 (0.51) BCKDKRAB9ALMNAMAPK1HPGD
SCHEMBL693146 0.82 BCKDK (0.68) BCKDKRAB9ALMNAMAPK1HPGD
SCHEMBL31015986 0.82 RXFP1 (0.51) BCKDKRAB9ALMNAMAPK1HPGD
SCHEMBL1805430 0.78 LMNA (0.69) IKBKBLMNAMAPK1HPGDKDM4E
SCHEMBL912462 0.78 RAB9A (0.49) BCKDKIKBKBRAB9ALMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118451066-A 3-Phenyl-1-benzothiophene-2-carboxylic acid derivatives as inhibitors of branched alpha ketoacid dehydrogenase kinase for the treatment of diabetes, kidney disease, NASH and heart failure 辉瑞大药厂 2024-08-06 CN disclosed